DNA lagging in the COVID-19 vaccine race: Data Byte

At the start of the pandemic, three major nucleic acid modalities were in the running to yield a COVID-19 vaccine, but only RNA and viral vector vaccines have made it across the finish line, leaving DNA vaccines behind.

But developers have not given up on DNA vaccines. Of the 64 disclosed nucleic acid COVID-19 vaccines in development, 42% are RNA vaccines, 30% are viral vectors, and about 27% are DNA vaccines.  ...